Safety and Efficacy of Evobrutinib and Tolebrutinib in Relapsing Multiple Sclerosis: A Meta-Analysis of Recent Randomized Control Trials

DOI: 10.1016/j.msard.2023.105297 Publication Date: 2023-12-18T12:36:39Z